WebApr 4, 2024 · Response was defined as: Improvement ≥ 20% in ≥ 3 of 5 participant-reported Sjogren's syndrome (SjS) related visual analogue score (VAS) measures (participant's assessment of global disease, pain, oral dryness, ocular dryness and fatigue), with no increase defined as > 30 mm from baseline (Day 1) in any of the above 5 VAS … WebReach out to one of our research coordinators: Susan Robinson [email protected] P: 410-550-6492. Freena Chaudhry, MS [email protected] P: 410-550-9821. Sjögren’s Syndrome Screening Dry Eye Study (SSDE Study) PI: Dr. Alan Baer; Co-Investigator: Dr. Esen Akpek
UCB Proof of Concept Study in Patients With Primary Sjögren
WebSep 13, 2024 · In the largest study of long-term safety outcomes for patients with breast implants, researchers at The University of Texas MD Anderson Cancer Center have found that silicone implants are associated with some rare diseases, autoimmune disorders and other conditions; although a causative relationship has not been established. Results of … WebNov 20, 2015 · Subject has a diagnosis of any other autoimmune disease, ie, secondary Sjögren's syndrome (eg, rheumatoid arthritis, systemic lupus erythematosus; Subject has a diagnosis of any other sicca syndrome (eg, history of head and neck radiation treatment, sarcoidosis chronic graft-versus-host disease) inwear yen
Sjogren
WebDec 4, 2024 · Potential participants will be recruited internationally online through social media and mailing lists for Sjogren's syndrome support groups. Adverts will direct people to download the self-management app on app stores (Apple App Store and Google Play). ... (Clinical Trial) Actual Enrollment : 996 participants: Allocation: Randomized ... WebSep 9, 2024 · This Extension study is a 48-week treatment study, with a safety follow-up period of 12 weeks. This study will evaluate the safety and tolerability of iscalimab at two dose levels in patients with Sjögren's Syndrome, who must have participated in the TWINSS core study, CCFZ533B2201 (NCT03905525) and must have completed the … WebJul 20, 2024 · The ESSDAI is a validated tool used in clinical studies to measure the systemic disease activity in participants with primary Sjogren's syndrome. The ESSDAI … onlyprinter